Investor Relations

Partnerships are integral to Harbour BioMed's strategy to build a fully integrated biopharmaceutical company.

  1. Sep 14, 2021

    HBM4003 Phase I Data Readout

  2. Aug 31, 2021

    2021 Interim Results Conference Call

  3. Jul 07, 2021

    HBM9161 MG Phase II Trial Topline Data Readout

  4. Jun 17, 2021

    2021 Investors Forum

  5. Mar 30, 2021

    2020 Annual Results Online Conference